Literature DB >> 2650271

HLA alloimmunization and blood requirements in orthotopic liver transplantation.

I R Marino1, T Weber, Y G Kang, C O Esquivel, T E Starzl, R Duquesnoy.   

Abstract

Mesh：

Year:  1989        PMID： 2650271      PMCID： PMC2967352     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  13 in total

1.  Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation.

Authors:  Y G Kang; D J Martin; J Marquez; J H Lewis; F A Bontempo; B W Shaw; T E Starzl; P M Winter
Journal:  Anesth Analg       Date:  1985-09       Impact factor: 5.108

2.  Refinements in the surgical technique of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; C O Esquivel; S Todo; I Kam; S Lynch; R D Gordon; B W Shaw
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

3.  Liver transplantation against T cell-positive warm crossmatches.

Authors:  S Iwatsuki; B S Rabin; B W Shaw; T E Starzl
Journal:  Transplant Proc       Date:  1984-12       Impact factor: 1.066

4.  Venous bypass in clinical liver transplantation.

Authors:  B W Shaw; D J Martin; J M Marquez; Y G Kang; A C Bugbee; S Iwatsuki; B P Griffith; R L Hardesty; H T Bahnson; T E Starzl
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

5.  Alloimmunization following platelet transfusion: the absence of a dose-response relationship.

Authors:  J P Dutcher; C A Schiffer; J Aisner; P H Wiernik
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

6.  Liver transplantation in man--IV, Haemorrhage and thrombosis.

Authors:  P T Flute; M O Rake; R Williams; M J Seaman; R Y Calne
Journal:  Br Med J       Date:  1969-07-05

7.  An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.

Authors:  J M Heal; N Blumberg; D Masel
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

8.  Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation.

Authors:  B W Shaw; R P Wood; R D Gordon; S Iwatsuki; W P Gillquist; T E Starzl
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

9.  Blood use in liver transplantation.

Authors:  J H Lewis; F A Bontempo; F Cornell; J E Kiss; P Larson; M V Ragni; E O Rice; J A Spero; T E Starzl
Journal:  Transfusion       Date:  1987 May-Jun       Impact factor: 3.157

10.  Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.

Authors:  Y Kang; J H Lewis; A Navalgund; M W Russell; F A Bontempo; L S Niren; T E Starzl
Journal:  Anesthesiology       Date:  1987-06       Impact factor: 7.892
View more
  5 in total

1.  Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.

Authors:  H R Doyle; I R Marino; F Morelli; C Doria; L Aldrighetti; J McMichael; J Martell; T Gayowski; T E Starzl
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

2.  Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?

Authors:  H R Doyle; I R Marino; N Jabbour; G Zetti; J McMichael; S Mitchell; J Fung; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

3.  The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors.

Authors:  S Takaya; O Bronsther; Y Iwaki; K Nakamura; K Abu-Elmagd; A Yagihashi; A J Demetris; M Kobayashi; S Todo; A G Tzakis
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

4.  Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance.

Authors:  R Mañez; R H Kelly; M Kobayashi; S Takaya; O Bronsther; D Kramer; R J Duquesnoy; Y Iwaki; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

5.  Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia.

Authors:  I R Marino; V P Scantlebury; O Bronsther; S Iwatsuki; T E Starzl
Journal:  Transpl Int       Date:  1992       Impact factor: 3.782
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.